Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

300015 Aier Eye Hospital Group

Watchlist
28.310
+1.210+4.46%
Market Close 12/01 15:00 CCT
High
28.700
Open
27.990
Turnover
2.15B
Low
27.940
Pre Close
27.100
Volume
757.63Klot
Market Cap
203.17B
P/E(TTM)
75.90
52wk High
35.439
Shares
7.18B
P/E(Static)
87.38
52wk Low
19.167
Float Cap
163.85B
Bid/Ask %
11.07%
Historical High
55.536
Shs Float
5.79B
Volume Ratio
2.63
Historical Low
0.327
Dividend TTM
0.092
Div Yield TTM
--
P/B
12.52
Dividend LFY
0.32%
Div Yield LFY
--
Turnover Ratio
1.31%
Amplitude
2.80%
Avg Price
28.339
Lot Size
100
Float Cap
163.85B
Bid/Ask %
11.07%
Historical High
55.536
Shs Float
5.79B
Volume Ratio
2.63
Historical Low
0.327
Dividend TTM
0.092
Limit Up
32.520
P/B
12.52
Dividend LFY
0.32%
Limit Down
21.680
Turnover Ratio
1.31%
Amplitude
2.80%
Avg Price
28.339
Lot Size
100
Ask
327.69Klot
Bid
416.88Klot
Price Forecast

No Data

News

Comment

Company Overview More
The company is a well-known global chain of ophthalmic medical institutions, IPO listed medical institutions (stock code: 300015, selected into the Shanghai and Shenzhen 300th index in 2015). By 2019, more than 300 professional eye hospitals had been established in 30 provinces, cities and autonomous regions of Chinese mainland, covering more than 70 percent of the country's health insurance population and more than 6.5 million outpatients annually. In addition, there are more than 80 eye hospitals in the United States, Europe and Hong Kong, China. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry and optometry. At present, the medical network has spread throughout Chinese mainland, Hong Kong, China, Europe, the United States and Southeast Asia. It has established the strategic pattern of global development. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry. The honors include Ayre Ophthalmology won the top 10 of China's "most respected listed companies by investors", Ayre Ophthalmology won the Best Sustainable Investment value Award, the most influential listed Company Leader Award, Gold Secret Award, Ayre Ophthalmology won the Best shareholder return Award of Chinese listed companies in 2017, and so on.
CEO: --
Market: --
Listing Date: 10/30/2009
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist